Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis

NCT00717366 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia

Interventions

DRUG: Methoxy Polyethylene Glycol-Epoetin Beta

Sponsor

Hoffmann-La Roche